Asia Pacific is expected to leadthe market promoting the utilization of immunoassays with the rise ininfectious diseases
Regional segmentation of the ImmunoassayInstruments Market by Coherent Market Insights comprises North America,Europe, Asia-Pacific, Latin America and Middle East and Africa. North Americais expected to dominate the global market owing to the rising demand fortechnologically advanced clinical diagnostic analyzers capable to performmultiple immunoassays simultaneously. According to the article published inGenetic Engineering and Biotechnology News (GEN), the market for infectiousdisease testing in the U.S. is expected to grow from U.S. $168 billion in 2015to U.S. $209 billion in 2020 owing to the upsurge of infectious diseases.Additionally, the rising grants from the government and the private healthcareagencies, contributing towards the development of technology andcommercialization of immunoassay analyzers, thereby raising the market in NorthAmerica. The immunoassay instruments market is expected to boost in AsiaPacific owing to the rising research activities in microbiology sector,increasing the prevalence of infectious and chronic diseases like cholera,tuberculosis, typhoid, autoimmune diseases and rising government healthcaregrants. For instance, China directed immunoassay market at an estimated U.S.$626 million in 2013 and is estimated to reach U.S. $1309 million by 2018.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/942
Immunoassay Instruments arebioanalytical devices used to perform automated biochemical tests for thedetection of various substances or specific proteins in the samples. Theimmunoassay instruments, also known as analyzers are used in hospitals andclinical laboratories to detect the concentration and presence of analytes inthe blood, plasma and urine samples. The immunoassay tests rely on the abilityof antibody binding to a specific structure of molecule present in theanalytes. The concentration of proteins is measured using the specificantigen-antibody binding properties. The quantification and identification ofproteins in the analyte sample is done by using the antibody as a reagent. Theadvantages of using immunoassay instruments are the minimal human resistance,simultaneous screening of multiple samples. The high sensitivity, reliability,and applicability to a range of compounds, distinctive selective and detectionabilities at extremely low concentrations of nanogram to pictogram makeimmunoassays a powerful tool.
A wide variety to address healthproblems drives the immunoassay instruments market
According to the DiseasePrevention and Health Promotion estimates in 2017, the immunoassay techniqueshave prevented up to 14 million lives with early diagnosis, reducing thehealthcare costs by $9.9 billion. The adoption of automated techniques to testvarious substances including antibiotic, anticonvulsant or cardiac glycosidedrug concentration determination, cancer markers, endocrine hormone testingdrives the market. Rising prevalence of infectious diseases with earlydiagnosis, prevention, and treatment is the main factor boosting the demand forcompact consumable products and instruments in the healthcare sector. Thelaunch of various FDA approved innovative products is expected to fuel thecommercialization of immunoassay instruments significantly in the forecastperiod. For instance, the launch of fluorescence scanning portable instrumentichroma II and enzyme-linked immunosorbant assay (ELISA) test cartridge byiStat cardiac Troponin I.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/immunoassay-instruments-market-942
Improved workflow owing to easeand comprehensive technology are the prominent factors estimated to boost theautomated immunoassay instrument market
The launch of automatedchemiluminescence immunoassay instrument by Abbott to rise the demand ofimmunoassay instruments
The key players operating theimmunoassay market are Siemens, Roche Diagnostics, Abbott Laboratories, DanaherCorporation, and BioMérieux SA. The innovative measures adopted by the leadingmanufacturers to perform different assays in a short time with minimal operatorintervention leads to the rising demand by the manufacturers. For instance, thelaunch of automated immunoassay instrument working on the principle ofchemiluminescence Architect i1000SR by Abbott offers high precision, goodperformance, and low detection limits. Other key vendors operating the marketare Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd, Siemens MedicalSolutions Diagnostics, and Trinity Biotech.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/942
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
